| 000 | 01356 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512013655.0 | ||
| 264 | 0 | _c19900319 | |
| 008 | 199003s 0 0 eng d | ||
| 022 | _a0010-7824 | ||
| 024 | 7 |
_a10.1016/0010-7824(89)90071-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurkman, R T | |
| 245 | 0 | 0 |
_aOral contraceptives and lipids and lipoproteins: Part II--Relationship to plasma steroid levels and outlier status. _h[electronic resource] |
| 260 |
_bContraception _cDec 1989 |
||
| 300 |
_a675-89 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aContraceptives, Oral, Combined _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEthinyl Estradiol _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 |
_aLipoproteins _xmetabolism |
| 650 | 0 | 4 |
_aNorethindrone _xblood |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aZacur, H A | |
| 700 | 1 | _aKimball, A W | |
| 700 | 1 | _aKwiterovich, P | |
| 700 | 1 | _aBell, W R | |
| 773 | 0 |
_tContraception _gvol. 40 _gno. 6 _gp. 675-89 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0010-7824(89)90071-1 _zAvailable from publisher's website |
| 999 |
_c2701168 _d2701168 |
||